logo
Cardiologists Are Begging People With Hypertension To Stop Doing This One Thing ASAP

Cardiologists Are Begging People With Hypertension To Stop Doing This One Thing ASAP

Yahoo12 hours ago
Cardiologists Are Begging People With Hypertension To Stop Doing This One Thing ASAP originally appeared on Parade.
Heart disease has the distinction of being the leading cause of death among U.S. adults. In 2025, the American Heart Association specifically called out hypertension as a risk factor that keeps heart disease at the top of this list. As scary as this sounds—especially if you have hypertension—cardiologists emphasize that it's important to know the truth so you can take action (which you can)."Hypertension poses a significant risk for the development of cardiovascular diseases, including heart attacks, strokes and congestive heart failure," says an interventional cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company. "Hypertension is treatable, and early interventions can significantly reduce the likelihood of these devastating conditions."Medications can help lower blood pressure. However, it's also important to make lifestyle tweaks, including understanding certain easy-to-overlook risks that can make hypertension worse. Cardiologists shared the one thing they're begging people with hypertension to stop doing ASAP, plus how to become a more informed (food) consumer.🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊
Cardiologists are urging people to be more mindful of their daily salt intake and not overlook the hidden ways sodium can be incorporated into foods. "Increased salt—sodium—intake affects how your kidneys manage the water balance in your body," explains , a board-certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center. "When you take in more sodium than you need, this will cause the body to retain water, which then leads to increased blood pressure in your blood vessels."
Dr. Chen echoes the American Heart Association's recommendation for daily salt intake, which is 2,300 mg per day. However, Dr. Chen adds that the American Heart Association recommends sticking to 1,500 mg per day for people with kidney or heart problems, and that includes hypertension.Related:
You may know not to add salt to foods if you have hypertension or want to keep blood pressure numbers in check. However, cardiologists say daily salt consumption is easy to underestimate. "Most people do not look at labels to see how much sodium they're consuming," points out Dr. Randy Gould, DO, a cardiologist with Manhattan Cardiology in NYC and labfinder.com contributor. "If they have foods that don't taste salty, they may think they're not high in sodium, but this might not be the case."
Indeed, salt is used for reasons beyond flavor, so taste testing isn't always the best way to gauge how much is in a meal or snack. Believe it or not, salt is in some of the sweetest foods (like cookies!)."Salt is hidden in many foods as both a flavor enhancer and preservative," Dr. Serwer reports. "For these reasons, salt is used in high quantities in many canned foods, prepared and processed meals and in commercial restaurants."
Related:
Still, it's possible to consume less salt. Dr. Chen recommends:
Checking the nutrition label on foods whenever possible
Preparing your own food with fresh ingredients more often than not
Ask for menu items that are lower in sodium when eating out
Dr. Serwer also recommends eating more home-cooked meals and especially avoiding fast food when eating out. Studiesconsistently show that people who eat out more frequently consume more sodium. He suggests:
Avoiding canned and pre-prepared meals (including ones you heat up in your own microwave)
Adding more produce to your diet
Considering salt substitutes for flavoring (like parsley, basil or cumin)
Related:
Keeping a keen eye on salt intake is essential. However, cardiologists recommend a holistic approach to tackling hypertension. They shared a few other ways to keep your blood pressure numbers in a healthy range.
Dr. Gould recommends getting at least 150 hours of physical activity per week. The American Heart Association recommends 150 minutes of moderate-intensity (exerting enough effort to breathe heavily but still able to talk) or 75 minutes of vigorous-intensity (a hard effort that causes heavy breathing, so you can only speak in short, choppy sentences) exercise each week for overall heart health. Research finds regular exercise is important for lowering and managing blood pressure.Dr. Serwer recommends discussing exercise programs with your doctor, especially if you have underlying health conditions.
The idea that stressful situations are "raising your blood pressure" may not be some tongue-in-cheek line. Dr. Gould states that stress management is a crucial tool for regulating blood pressure. Some studies show that tools like mindfulness-based stress reduction programs are effective. Stress can leave you tossing and turning at night, but Dr. Gould notes it's vital to catch enough Zzz's. A Hypertension study linked irregular sleep patterns to hypertension.Excessive drinking and smoking are two ways people may try to manage stress, but Dr. Chen advises against them, saying neither will do your heart (or overall health) any favors. Your care team can recommend resources to help you with these habits, such as therapy and support groups.
Dr. Serwer reminds people that doctors, such as cardiologists, are here to help. "Maintain a close and consistent relationship with your primary care providers and take your medications on time," he says.Additionally, you may need to check your blood pressure regularly. He advises people to heed these recommendations from their care team because it can help flag irregular blood pressure. `
Up Next:Heart and Stroke Statistics. American Heart Association.
Dr. Bradley Serwer, MD, an interventional cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company
Dr. Cheng-Han Chen, MD, a board-certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center
Shaking the Salt Habit to Lower High Blood Pressure. American Heart Association.
Dr. Randy Gould, DO, a cardiologist with Manhattan Cardiology in NYC and labfinder.com contributor
Can Meals Outside Homes Impact Sodium Intake? Current Developments in Nutrition.
Frequency of eating home cooked meals and potential benefits for diet and health: cross-sectional analysis of a population-based cohort study. International Journal International Journal of Behavioral Nutrition and Physical Activity.
American Heart Association Recommendations for Physical Activity in Adults and Kids. American Heart Association.
Exercise as a tool for hypertension and resistant hypertension management: current insights. Integrated Blood Pressure Control.
Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension: A Meta-Analysis of Randomized Controlled Trials. Hypertension.
Sleep Irregularity Is Associated With Hypertension: Findings From Over 2 Million Nights With a Large Global Population Sample. Hypertension.
Cardiologists Are Begging People With Hypertension To Stop Doing This One Thing ASAP first appeared on Parade on Jul 6, 2025
This story was originally reported by Parade on Jul 6, 2025, where it first appeared.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health
Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

Yahoo

time31 minutes ago

  • Yahoo

Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditure* LOS ANGELES, July 07, 2025--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the launch of MultiBurn™ — a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health*. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™ is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. As consumers continue to seek weight loss solutions, Herbalife offers an innovative, non-pharmaceutical approach with MultiBurn™, a product grounded in science-backed ingredients and a continued commitment to wellness innovation. Built on a foundation of clinical research, MultiBurn™ features a powerful blend of three botanical ingredients: Morosil™ (from Moro blood oranges): supports overall weight loss, including reduced hip and waist circumference and a healthy BMI ‡*. Metabolaid® (hibiscus and lemon verbena extract): helps with healthy reduction of fat and increased feeling of fullness after meals ‡*. Capsifen™ (red chili pepper and fenugreek blend): supports healthy energy expenditure*. MultiBurn™ also contains supporting functional ingredients, including caffeine to stimulate metabolism and provide a feeling of energy and alertness*, and chromium to aid in maintaining blood sugar levels already within the normal range*. "MultiBurn™ was developed using scientific insight into the underlying mechanisms of metabolic health and the challenging cycle of weight gain," said John Heiss, Ph.D., vice president of Global Product Innovation at Herbalife. "Our team carefully selected and combined ingredients based on their botanical profiles and the findings within published, human randomized controlled clinical studies to create an evidence-based solution for weight loss and healthy fat loss*." MultiBurn™ is designed for daily use as part of a balanced healthy lifestyle, with three capsules taken once a day alongside breakfast or lunch. While its ingredients have been shown to be effective individually, MultiBurn™ is recommended to be paired with consistent healthy habits, including a nutritious diet and regular physical activity. It can also be integrated into a broader Herbalife routine, complementing products such as high-protein shakes, fiber supplements and targeted wellness solutions — all supported by Herbalife's global community of Independent Distributors who provide personalized guidance to millions of customers to achieve their weight loss and wellness goals. "Maintaining metabolic health is central to overall wellness and effective weight loss," said Dr. Luigi Gratton, vice president of Health & Wellness at Herbalife. "It supports how the body converts food into energy, regulates hormones and blood sugar, and influences brain function, sleep and mood. Sustainable results come from balanced nutrition, regular physical activity and quality rest, with targeted supplementation like MultiBurn™ providing additional support to help individuals achieve their long-term health goals." For 45 years, Herbalife has been committed to personalized nutrition and science-backed wellness. The company's very first product, Formula 1 Healthy Meal Nutritional Shake Mix, revolutionized meal replacement nutrition and is the #1 protein shake in the world1 — sold in over 90 countries and trusted by millions. Recognized as the #1 active and lifestyle nutrition brand in the world2, Herbalife offers an extensive portfolio of products designed to support healthy weight management, sports performance, daily nutrition and promote skin and body care to help individuals at every stage of their wellness journey. MultiBurn™ builds on this legacy as part of Herbalife's ongoing evolution, bringing together clinical research, ingredient transparency and innovative formulation to address the modern consumer demand for whole-person wellness. MultiBurn™ is now available in the United States, and will be launching in Puerto Rico in September 2025. For more information on MultiBurn™, please click here. Herbalife products are available exclusively through Herbalife Independent Distributors. To purchase Herbalife's MultiBurn™ in the United States or Puerto Rico, consumers can call 1-888-443-7225. For specific questions about using Herbalife products with other weight-loss therapies, contact Herbalife's dedicated team of health and safety professionals at GCS@ * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ‡ In combination with a healthy diet and active lifestyle. Morosil™ is a trademark owned by Bionap Srl Metabolaid® is a registered trademark of Monteloeder, S.L Capsifen™ is a trademark of Akay USA, LLC, an Oterra company (1) Source: Euromonitor; CH2025ed, protein shake as sports protein powder, sports protein RTDs, meal replacement, supplement nutrition drinks & protein supplements; combined % RSP share GBO for 2024. (2) Source: Euromonitor; CH2025ed, active & lifestyle nutrition as weight management & wellbeing, sports nutrition and vitamins & dietary supplements definitions; combined % RSP share GBO for 2024. RTD = Ready to Drink; RSP = Retail Selling Price; GBO = Global Brand Owner About Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its Independent Distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit View source version on Contacts Media Contact: media@

US FDA approves KalVista Pharma's swelling disorder drug, shares rise
US FDA approves KalVista Pharma's swelling disorder drug, shares rise

Yahoo

time39 minutes ago

  • Yahoo

US FDA approves KalVista Pharma's swelling disorder drug, shares rise

By Puyaan Singh (Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares up more than 17% in premarket trading. The regulator's decision follows an extended review of the drug last month due to heavy workloads and limited resources. Ekterly, which offers a convenient alternative to injectable treatments, will be launched immediately, the company said. KalVista CEO Ben Palleiko said patients find it 'really burdensome' to carry injectable treatments, which are 'almost twice the size of an iPhone,' while Ekterly is packaged 'in a little cardboard wallet, about the size of a credit card.' Other on-demand treatments for hereditary angioedema, which affects about 8,000 people in the United States, include CSL's Berinert, Takeda's Cinryze, and Pharming's Ruconest, which are administered intravenously, as well as injectables such as Takeda's Kalbitor and Firazyr. Needham analyst Serge Belanger said KalVista previously indicated it would likely price Ekterly at a slight premium to Firazyr, the most commonly used on-demand treatment, which costs $11,000 per unit. The life-threatening condition causes sudden, dangerous swelling in the body, including the skin, digestive tract and upper respiratory system, due to deficiency in a protein known as C1 inhibitor. Citizens Bank analyst Jonathan Wolleben estimates peak U.S. sales of Ekterly at around $250 million, adding the early launch could exceed expectations due to potential premium pricing and rapid adoption. Approval of the drug was based on a trial in which Ekterly achieved the beginning of symptom relief in 1.6 hours, while a later trial showed the drug could treat attacks in 10 minutes, the company said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

June Jobs Data Puts Focus on Healthcare ETFs & Stocks
June Jobs Data Puts Focus on Healthcare ETFs & Stocks

Yahoo

time39 minutes ago

  • Yahoo

June Jobs Data Puts Focus on Healthcare ETFs & Stocks

Nonfarm payrolls in the United States rose by 147,000 in June 2025, following an upwardly revised 144,000 in May and surpassing forecasts of 110,000. The reading was also in line with the average monthly gain of 146K over the prior 12 months. The U.S. unemployment rate edged down to 4.1% in June 2025 from 4.2% in May, defying market expectations of a rise to 4.3%. The rate has held within a narrow 4.0-4.2% band since May 2024, signaling broad labor market stability. The number of unemployed dropped by 222,000 to 7.015 million, while employment rose modestly by 93,000 to 163.366 million. However, the overall labor force shrank by 130,000 to 170.380 million. Average hourly earnings for all employees on private nonfarm payrolls rose by 8 cents, or 0.2%, to $36.30 in June. Over the past 12 months, average hourly earnings increased by 3.7%. In June, average hourly earnings of private-sector production and nonsupervisory employees rose by 9 cents, or 0.3%, to $31.24. Below, we have highlighted the sector and its related exchange-traded funds (ETFs) that will likely experience smooth trading in the days ahead in light of the June jobs data. Healthcare Healthcare added 39,000 jobs in June, similar to the average monthly gain of 43,000 over the prior 12 months. In June, job gains were noted in hospitals (+16,000) and in nursing and residential care facilities (+14,000). Health Care Select Sector SPDR ETF XLV can be played to tap the moderate momentum, although Trump's tax bill may lead millions of Americans to lose healthcare coverage. The fund has 30% exposure to the pharma industry, followed by 22.32% exposure to the healthcare providers & services industry, about 22% focus on Health Care Equipment & Supplies, 17.1% focus on the biotech sector and 8.7% focus on the life sciences tools & services. iShares U.S. Healthcare Providers ETF IHF concentrates on companies in the healthcare provider and services sector. The underlying Dow Jones U.S. Select HealthCare Providers Index is a free-float adjusted market capitalization-weighted index. It measures the performance of the healthcare providers sub-sector of the U.S. equity market. It includes health maintenance organizations, hospitals, clinics, dentists, opticians, nursing homes, rehabilitation & retirement centres. The fund charges 40 bps in fees. Vanguard Health Care ETF VHT tracks the MSCI US Investable Market Health Care 25/50 Index made up of stocks of U.S. companies in the healthcare sector. The fund charges 9 bps in fees and sports a Zacks Rank #1. HCA Healthcare HCA, which has a Zacks Rank #3 (Hold), deserves a mention. It is the largest non-governmental operator of acute care hospitals in the United States. The company has a trailing four-quarter earnings surprise of 7.06%, on average. Welltower WELL is a real estate investment trust (REIT) that is engaged in investments with seniors housing operators, post-acute providers and health systems. The company has a trailing four-quarter earnings surprise of 4.24%, on average. Zacks Rank #2 Omega Healthcare Investors OHI is a self-administered real estate investment trust (REIT), investing in income-producing healthcare facilities, principally long-term care facilities located in the United States and the United Kingdom. The company has a trailing four-quarter earnings surprise of 2.13%, on average. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omega Healthcare Investors, Inc. (OHI) : Free Stock Analysis Report HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report Health Care Select Sector SPDR ETF (XLV): ETF Research Reports Vanguard Health Care ETF (VHT): ETF Research Reports iShares U.S. Healthcare Providers ETF (IHF): ETF Research Reports Welltower Inc. (WELL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Inicia sesión para acceder a tu portafolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store